General enquiry

PrimeCoreBio English/Thai Product Records/Mounjaro

THAILAND · ENGLISH PRODUCT EVIDENCE PROFILE

Mounjaro
in Thailand

Product identity, Thai indication boundaries and evidence context. This is not a sales page or individual treatment guidance.

Mounjaro official manufacturer reference image
OFFICIAL MANUFACTURER IMAGE · REFERENCE ONLY

Mounjaro product reference image

Direct manufacturer image without a third-party watermark. Packaging and presentations may vary by country and time. The image does not authenticate an item submitted for verification and is not a product listing.

Image source: Mounjaro — Lilly current medicines ↗

QUICK ANSWER · AEO / GEO

Mounjaro is a tirzepatide product. The reviewed Thai FDA record lists type 2 diabetes and weight management in defined adults. The reviewed Thai record did not display an obstructive sleep apnoea indication, so the US Zepbound indication should not be transferred to Mounjaro in Thailand.

01

THAI INDICATION BOUNDARY

What does the reviewed Thai record indicate?

THAI FDA RECORD1

Type 2 diabetes in conjunction with diet and exercise, under the conditions stated in the Thai record.

THAI FDA RECORD2

Weight management in adults with obesity or overweight plus at least one weight-related condition.

NOT DISPLAYED IN REVIEWED RECORD3

OSA was not displayed as an indication in the reviewed Thai Mounjaro record.

02

PRODUCT IDENTITY

Mounjaro is not every Tirzepatide product

  • The product name, registration, formulation and authorised holder must match.
  • An identical active ingredient does not make indications interchangeable between brands.
  • Unofficial packaging or an unverified label does not establish identity, quality or approval.
03

SAFETY BOUNDARY

Prescription and high-risk context

Professional assessment required

Contraindications, gastrointestinal effects, pancreatitis and gallbladder risks, dehydration, interactions and individual medical history require current product information and a qualified professional.

  • Population-level study outcomes do not predict an individual's response.
  • Safety information must match the exact product and current Thai documentation.
  • This page does not provide dosage, administration or injection instructions.
04

FAQ · ANSWER ENGINE

Frequently asked questions

What is Mounjaro?

Mounjaro is a product containing Tirzepatide. Its identity, formulation, jurisdiction and indications must be assessed as a specific product.

Is Mounjaro registered in Thailand?

PrimeCoreBio found the reviewed Thai product record 1C 21/67 (NC). Regulatory status is time-sensitive and should be checked against the current official record.

Does this page provide dosage or injection instructions?

No. It contains no price, purchasing, dosage, administration or injection protocol and does not replace professional medical advice.

05

SOURCE TRANSPARENCY

Primary and supporting sources

  1. อย. ไทย — ระเบียน MounjaroPrimary regulatory record · https://pertento.fda.moph.go.th/FDA_SEARCH_DRUG/SEARCH_DRUG/pop-up_drug.aspx?Newcode_U=U1DR1C1012670002111C&drgtpcd=1&pvncd=10
  2. อย. ไทย — ระเบียน Mounjaro KwikPenPrimary regulatory record · https://pertento.fda.moph.go.th/FDA_SEARCH_DRUG/SEARCH_DRUG/pop-up_drug.aspx?Newcode_U=U1DR1C1012670004111C
  3. Tirzepatide Evidence ProfilePrimeCore evidence synthesis · /molecules/tirzepatide
Medical Disclaimer

Educational information only. Not diagnosis, treatment, prescribing, dosage, administration, injection guidance or individual medical advice.

LINE · สอบถามข้อมูลทั่วไปติดต่อฝ่ายข้อมูลทั่วไปLINE · GENERAL SUPPORTGeneral enquiries@primecoreสำหรับข้อมูลทั่วไปเท่านั้น · ไม่มีบริการด้านการขายหรือคำแนะนำทางการแพทย์General information only · No sales or medical advice